Table 1. Long-term studies on... | American Society of Hematology

Table 1.

Long-term studies on hydroxyurea use in children with sickle cell disease

	Reference 6	Reference7	Reference 8
No. patients at inclusion	84	101	93
Mean age at inclusion (y)	9.8 ± 3.2	9.8 ± 0.4	7
No. patients after 2 y	35	45	61
No. patients after 3 y	ND	36	44
Malignancy	0	1, not related to HU	0

	Reference 6	Reference7	Reference 8
No. patients at inclusion	84	101	93
Mean age at inclusion (y)	9.8 ± 3.2	9.8 ± 0.4	7
No. patients after 2 y	35	45	61
No. patients after 3 y	ND	36	44
Malignancy	0	1, not related to HU	0

ND indicates not determined.